We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+12.3%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$51B
AUM Growth
+$15.4B
Cap. Flow
+$11.4B
Cap. Flow %
22.45%
Top 10 Hldgs %
32.55%
Holding
2,383
New
382
Increased
1,739
Reduced
215
Closed
45

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$973M
2
MSFT icon
Microsoft
MSFT
+$944M
3
META icon
Meta Platforms (Facebook)
META
+$686M
4
AMZN icon
Amazon
AMZN
+$561M
5
NVDA icon
NVIDIA
NVDA
+$341M

Top Sells

Rank Stock Value
1
LEG icon
Leggett & Platt
LEG
+$127M
2
PBCT
People's United Financial Inc
PBCT
+$25.8M
3
ALB icon
Albemarle
ALB
+$25.2M
4
CDW icon
CDW
CDW
+$25.2M
5
FDS icon
Factset
FDS
+$23.1M

Sector Composition

Rank Sector Weight
1 Technology 33%
2 Consumer Discretionary 13.39%
3 Communication Services 11.47%
4 Healthcare 9.06%
5 Consumer Staples 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACTG icon
2276
Acacia Research
ACTG
$439M
$55K ﹤0.01%
+10,714
New +$57.8K
BDTX icon
2277
Black Diamond Therapeutics
BDTX
$104M
$53K ﹤0.01%
10,082
-573
-5% -$4K
SB icon
2278
Safe Bulkers
SB
$729M
$52K ﹤0.01%
+13,848
New +$56.4K
SCOR icon
2279
Comscore
SCOR
$112M
$52K ﹤0.01%
+765
New +$54.8K
SMMT icon
2280
Summit Therapeutics
SMMT
$10.5B
$52K ﹤0.01%
19,518
-4,663
-19% -$22.4K
TXMD icon
2281
TherapeuticsMD
TXMD
$24.4M
$52K ﹤0.01%
2,900
+90
+3% +$2.7K
CGEN icon
2282
Compugen
CGEN
$221M
$51K ﹤0.01%
11,821
-6,112
-34% -$33.1K
XERS icon
2283
Xeris Biopharma Holdings
XERS
$1.48B
$51K ﹤0.01%
17,561
+3,356
+24% +$7.25K
BOLT icon
2284
Bolt Biotherapeutics
BOLT
$8.59M
$50K ﹤0.01%
+512
New +$97.2K
ESPR
2285
DELISTED
Esperion Therapeutics
ESPR
$50K ﹤0.01%
+10,015
New +$80.2K
SMSI icon
2286
Smith Micro Software
SMSI
$14.2M
$50K ﹤0.01%
+252
New +$55.1K
DRRX
2287
DELISTED
DURECT Corp
DRRX
$49K ﹤0.01%
4,942
+2,043
+70% +$22.6K
SLDB icon
2288
Solid Biosciences
SLDB
$832M
$49K ﹤0.01%
+1,904
New +$58.2K
VIRX
2289
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$49K ﹤0.01%
+13,174
New +$70.3K
MBIO icon
2290
Mustang Bio
MBIO
$4.94M
$48K ﹤0.01%
+39
New +$63K
TK icon
2291
Teekay
TK
$936M
$48K ﹤0.01%
+15,173
New +$52.4K
URG
2292
Ur-Energy
URG
$481M
$48K ﹤0.01%
39,535
+16,349
+71% +$26.8K
NMTR
2293
DELISTED
9 Meters Biopharma
NMTR
$48K ﹤0.01%
2,473
+1,042
+73% +$23.3K
KG
2294
Kestrel Group
KG
$74.9M
$47K ﹤0.01%
+759
New +$48K
SIEN
2295
DELISTED
Sientra, Inc.
SIEN
$47K ﹤0.01%
+1,268
New +$61.4K
SFT
2296
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$47K ﹤0.01%
+1,356
New +$74.3K
ATNX
2297
DELISTED
Athenex, Inc. Common Stock
ATNX
$46K ﹤0.01%
1,714
-8
-0.5% -$338
MILE
2298
DELISTED
Metromile, Inc. Common Stock
MILE
$46K ﹤0.01%
+20,946
New +$59.7K
QTNT
2299
DELISTED
Quotient Limited Ordinary Shares
QTNT
$45K ﹤0.01%
429
+178
+71% +$17.1K
ALDX icon
2300
Aldeyra Therapeutics
ALDX
$103M
$43K ﹤0.01%
+10,602
New +$80.9K
90 91
92
93 94

Similar funds

Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

ProShare Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, ProShare Advisors held 2,383 positions worth $51B, up 43% from $35.6B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

ProShare Advisors deployed $11.4B of net new capital in Q4 2021, opening 382 new positions and adding to 1,739 existing holdings. Its largest new stake was Lucid Motors: 272,628 shares worth $104M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Leggett & Platt, an estimated $127M trimmed.

  • ProShare Advisors's largest Q4 2021 buy was Lucid Motors: 272,628 shares worth $104M.
  • ProShare Advisors added most to Apple in Q4 2021, an estimated $973M increase.
  • ProShare Advisors's biggest Q4 2021 reduction was Leggett & Platt, cutting an estimated $127M.
  • ProShare Advisors fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $20.9M.
  • ProShare Advisors's ten largest holdings make up 33% of its $51B portfolio in Q4 2021.
  • ProShare Advisors opened 382 new positions and closed 45 in Q4 2021.
  • ProShare Advisors's portfolio value rose 43% quarter-over-quarter to $51B.

Based on ProShare Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.